Connect with us

Technology

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

Published

2 months ago

on

Cloud-based platform provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settingsAvailable within NxStage® System One™ with NxView™ 4.0, Fresenius Medical Care’s FDA 510(k)-cleared software platform for kidney replacement therapy in the United StatesAggregates existing therapy and device data to support identification of trends related to workflow interruptions, alarm burden, and variability

BAD HOMBURG, Germany, July 20, 2026 /PRNewswire/ — Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced the introduction of TherapyWise™, a cloud-based analytics capability available within NxView™ 4.0, the Company’s FDA 510(k)-cleared software platform for use with the NxStage® System One™ in the United States. TherapyWise is designed to provide retrospective, program-level insight into kidney replacement therapy (KRT) delivered in acute and hospital critical care settings.

Kidney replacement therapy in the Intensive Care Unit (ICU) generates large volumes of clinical and operational data, yet trends related to therapy delivery, workflow interruptions, and alarm frequency can be difficult to assess without standardized metrics and aggregated views. TherapyWise consolidates existing data generated at the point of care and presents longitudinal summaries intended to support oversight of KRT programs across ICU units and time periods.

“Digital solutions play an increasingly important role in how critical care teams understand and manage complex therapies,” said Joe Turk, Chief Executive Officer of Care Enablement at Fresenius Medical Care. “TherapyWise reflects our continued focus on innovation in critical care by applying data analytics. This helps hospital and clinical leaders gain visibility into how kidney replacement therapy is delivered across their organizations, supporting informed discussions around workflow, consistency, and quality improvement.”

TherapyWise works by securely transmitting data from the NxStage System One with NxView to a cloud‑based platform, where information is aggregated and displayed across predefined performance indicators. These include program‑level metrics including average delivered dose compared with set dose, average treatment time per cartridge, and alarm frequency trends. The software is intended to support retrospective review and program oversight and is not designed for real‑time, patient‑specific clinical decision‑making, which remains the responsibility of attending clinicians.

TherapyWise is part of Fresenius Medical Care’s NxView 4.0 software platform and broader critical care portfolio, which combines digital infrastructure, clinical expertise, and secure data management to support hospital teams responsible for kidney replacement therapy programs.

To learn more about TherapyWise, please visit https://freseniusmedicalcare.com/en-us/products/critical-care/therapywise/.

About Fresenius Medical Care:
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases of which around 4.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,539 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approx. 290,000 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

For more information visit the company’s website at www.freseniusmedicalcare.com.

Disclaimer:
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care’s reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care does not undertake any responsibility to update the forward-looking statements in this release.

Media contact
Christine Peters
T +49 160 60 66 770
christine.peters@freseniusmedicalcare.com 

Kirsten Stratton
T +1 781 929 8096
kirsten.stratton@freseniusmedicalcare.com 

Contact for analysts and investors
Dr. Dominik Heger
T +49 6172 609 2525
dominik.heger@freseniusmedicalcare.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-therapy-302829320.html

SOURCE Fresenius Medical Care Holdings, Inc.

Related Topics:
Continue Reading

Technology

Huntington Bancshares Incorporated Announces Third Quarter 2026 Earnings Call Details

Published

37 minutes ago

on

September 30, 2026

By

COLUMBUS, Ohio, Sept. 30, 2026 /PRNewswire/ — Huntington Bancshares Incorporated (Nasdaq: HBAN) will release third quarter 2026 financial results prior to the market opening on Thursday, October 22, 2026. A news release and supporting financial data will be available at that time on the Investor Relations section of the Company’s website (www.huntington-ir.com).

The Company will host a conference call to review quarterly financial results at 9 a.m. ET.

Webcast Information

The third quarter 2026 earnings conference call, along with slides, may be accessed via a live Internet webcast in the Investor Relations section of Huntington’s website or through a dial-in telephone number at (877) 407-8029 or (201) 689-8029; conference ID # 13762987.

A replay of the webcast will be archived in the Investor Relations section of Huntington’s website. A telephone replay will be available approximately three hours after the completion of the call through Friday, October 30, 2026, at (877) 660-6853 or (201) 612-7415; conference ID # 13762987.

About Huntington

Huntington Bancshares Incorporated is a $284 billion asset regional bank holding company headquartered in Columbus, Ohio. A top 10 U.S. commercial bank, The Huntington National Bank and its affiliates provide consumers, small and middle-market businesses, corporations, municipalities, and other organizations with a comprehensive suite of banking, payments, wealth management, and risk management products and services. Founded in 1866, Huntington operates over 1,400 branches in 21 states, with certain businesses operating nationally. Visit Huntington.com for more information.

View original content to download multimedia:https://www.prnewswire.com/news-releases/huntington-bancshares-incorporated-announces-third-quarter-2026-earnings-call-details-302894994.html

SOURCE Huntington Bancshares Incorporated

Continue Reading

Technology

Media Advisory: Conference call for the release of the consolidated results of Quebecor Inc. for the third quarter 2026

Published

37 minutes ago

on

September 30, 2026

By

MONTREAL, Sept. 30, 2026 /CNW/ — Pierre Karl Péladeau, President and Chief Executive Officer, Quebecor Inc. and Quebecor Media Inc. and Hugues Simard, Chief Financial Officer, Quebecor Inc. and Quebecor Media Inc. will hold a conference call on Thursday, November 5th, 2026, at 9:00 AM, following the release of Quebecor Inc.’s consolidated results for the third quarter 2026. Media are invited to access the call on a listen-only basis.

Conference call:

Quebecor Inc. reports third quarter 2026 consolidated results
Thursday, November 5th, 2026, at 9:00 AM,

Call-in number:   

1-800-990-4777 (North America)
Or 514-400-3794 (Greater Montréal area)

To join the conference call without operator assistance, please register and
enter your telephone number at the following address to receive an instant
automatic callback: https://emportal.ink/4gxxWlc 

Speakers:       

Pierre Karl Péladeau, President and Chief Executive Officer,
Quebecor Inc. and Quebecor Media Inc.;
Hugues Simard, Chief Financial Officer, Quebecor Inc. and  
Quebecor Media Inc.

Anyone unable to attend the conference call will be able to listen to an audio webcast available on the Quebecor website at https://www.quebecor.com/en/investors/conferences-and-annual-meeting until February 3rd, 2027.

The Company
Quebecor, a Canadian leader in telecommunications, entertainment, news media and culture, is one of the best-performing integrated communications companies in the industry. Driven by their determination to deliver the best possible customer experience, all of Quebecor’s subsidiaries and brands are differentiated by their high-quality, multiplatform, convergent products and services.

Québec-based Quebecor (TSX: QBR.A, QBR.B) employs more than 11,000 people in Canada.

Since its founding in 1950, Quebecor has been strongly committed to the community, in line with the values of its founder, Pierre Péladeau. Every year, it actively supports more than 400 organizations in the vital fields of culture, health, education, the environment and entrepreneurship.

Visit our website: www.quebecor.com 

SOURCE Québecor

Continue Reading

Technology

Commvault Achieves AWS Data Competency in Relational Databases Category

Published

37 minutes ago

on

September 30, 2026

By

TINTON FALLS, N.J., Sept. 30, 2026 /PRNewswire/ — Commvault (NASDAQ: CVLT), a leader in unified resilience at enterprise scale, today announced that it has achieved the AWS Data Competency in the Relational Database category. This designation recognizes Commvault for its demonstrated expertise delivering unified data architectures on Amazon Web Services (AWS), helping customers build the data foundations that power modern analytics and AI workloads.

Achieving the AWS Data Competency differentiates Commvault as a member of the AWS Partner Network (APN) with deep technical proficiency and proven customer success delivering data solutions on AWS. The Data Competency validates partners across the full data lifecycle—from databases and analytics to streaming, data engineering, and AI-ready foundations—reflecting how customers build and modernize their data architectures.

Commvault achieved the AWS Data Competency in the Relational Databases category by delivering cyber-resilient data protection for relational database workloads on AWS, helping customers securely protect, recover, and manage business-critical data across Amazon Relational Database Service (RDS) environments. Commvault solutions delivered via SaaS, software, or appliance help organizations protect Amazon RDS and Amazon Aurora with automated backups, point-in-time recovery, and immutable, air-gapped storage, reducing complexity while improving cyber resilience and recovery readiness.

“Achieving the AWS Data Competency in Relational Databases reflects our continued commitment to helping organizations get more value from their data while strengthening resilience on AWS,” said Brian Lanigan, Chief Partner Officer, Commvault. “As enterprises accelerate AI initiatives and modernize critical workloads on AWS, Commvault enables them to recover their data with confidence, reducing complexity and helping keep their information ready to drive innovation and business outcomes.”

AWS is enabling scalable, flexible, and cost-effective solutions from startups to global enterprises. To support the seamless integration and deployment of these solutions, the AWS Competency Program helps customers identify AWS Partners with deep industry experience and expertise across industries, use cases, and workloads to help grow their business.

Commvault holds numerous service validations, certifications, and AWS competencies, including the AWS Storage Competency and AWS Resilience Competency in the Recovery category.

To learn more about Commvault’s support for AWS, visit https://www.commvault.com/supported-technologies/amazon/aws.

About Commvault
Commvault (NASDAQ: CVLT) is a leader in unified resilience at enterprise scale. In a constantly evolving threat landscape, Commvault keeps customers ready by unifying data security, identity resilience, and cyber recovery, on one cloud-native, AI-enabled platform. Customers trust Commvault to conduct the fastest, most complete recoveries – not just their data, but their entire business. Purpose-built for the agentic enterprise, Commvault also enables organizations to safely embrace AI while protecting against AI-driven threats.

View original content to download multimedia:https://www.prnewswire.com/news-releases/commvault-achieves-aws-data-competency-in-relational-databases-category-302894615.html

SOURCE COMMVAULT

Continue Reading

Trending